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ABSTRACT: Introduction: This study aimed at reviewing the literature 
on the aspects of the use of phytotherapeutic drugs, medicinal products 
made from the extraction of active compounds from unprocessed 
plants, undergoing industrial processes. Therefore, the most commonly 
used phytotherapeutic substances, the prevalence of this practice, the 
advantages and disadvantages of its use, and the profile and evaluation 
of Universal Health Care users were identified. Material and Methods: 
The bibliographic research comprised of articles published within the 
period from 2014 to 2018 in the SciELO and Lilacs databases. The 
keywords “fitoterapia” (phytotherapy) and “medicamentos fitoterápicos” 
(phytotherapeutic drugs) were used, three hundred and fifty-three articles 
were found in SciELO database, yet only twenty-one were selected for 
reading, and thirteen were used to write this article. In comparison, in 
the Lilacs database, one thousand, four hundred and ninety articles were 
located, forty-six selected for reading, and only eight were utilized for 
preparing the article. The others were eliminated based on their titles, 
repetition, or because they did not adhere to the inclusion criteria. Results 
and Discussion: Four categories were created based on the twenty-one 
selected articles: the most commonly used phytotherapeutic medicine, 
the prevalence of phytotherapy use, advantages and disadvantages of 
the practice, profile, and evaluation of Universal Health Care users. 
Conclusion: The most commonly used phytotherapeutic medicine are 
Guaco (Mikania glomerata), medication made of Passiflora (passion 
fruit), green tea, and phytotherapeutic drugs extracted from Curcuma 
(Turmeric).  There is a low prevalence of the practice, as indicated by 
the majority of the studies. As a disadvantage, it is possible to mention 
the insufficient knowledge by health professionals and the inadequate 
supply of phytotherapeutic drugs by the Universal Health Care system. 
On the other hand, the improvement of the doctor-patient bond is a 
positive aspect of using phytotherapeutic medication. The user profile 
includes women and individuals over 50 years old, who take the majority 
of phytotherapeutic drugs. Further studies on phytotherapy are needed, 
aiming at disseminating care provision that tightens the bond between 
the population and its ethnic-cultural singularities.
Keywords: Phytotherapy; Phytotherapeutic drugs. 
RESUMO: Introdução: Este trabalho realizou uma revisão de literatura 
acerca de aspectos do uso de fitoterápicos, medicamentos compostos 
a partir da extração de matérias primas vegetais ativas, que passam 
por um processo de industrialização. Dessa forma, identificaram-se os 
fitoterápicos mais utilizados, a prevalência de utilização dessa prática, 
vantagens e desvantagens de seu uso e o perfil e avaliação de usuários 
do Sistema Único de Saúde. Material e Métodos: Realizou-se um 
levantamento bibliográfico do período de 2014 a 2018 nas bases de 
dados SciELO e Lilacs. Foram utilizados os descritores “fitoterapia” e 
“medicamentos fitoterápicos”, sendo encontrados 353 artigos da base 
SciELO, sendo somente 21 selecionados para leitura e 13 utilizados para 
formar o artigo, enquanto na base de dados Lilacs 1490 artigos foram 
encontrados, 46 selecionados para leitura e 8 utilizados para elaborar o 
artigo. Os demais foram eliminados pelo título, por repetição ou por não 
se encaixarem nos critérios de inclusão. Resultados e Discussão: A partir 
dos 21 artigos selecionados, o conteúdo destes foi agrupado em quatro 
categorias: fitoterápicos mais utilizados, prevalência do uso da fitoterapia, 
vantagens e desvantagens da prática e perfil e avaliação dos usuários do 
Sistema Único de Saúde. Conclusão: Os fitoterápicos mais utilizados 
são o Guaco (Mikania glomerata), medicamentos à base de Passiflora, 
chá verde e fitoterápicos a base de Curcuma. A prevalência do uso é 
apontada como baixa pela maior parte dos estudos. Como desvantagem 
menciona-se o desconhecimento de profissionais de saúde e a menor oferta 
de medicamentos fitoterápicos pelo Sistema Único de Saúde, por outro 
lado, o estreitamento do vínculo médico-paciente é um aspecto positivo 
do uso dos fitoterápicos. Os usuários que fazem mais uso da fitoterapia 
são mulheres e indivíduos acima de 50 anos. São necessários mais estudos 
sobre a fitoterapia, buscando difundir uma produção de cuidado que se 
aproxime da população dentro de suas particularidades étnico-culturais.
Descritores: Fitoterapia; Medicamentos fitoterápicos. 
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INTRODUCTION
In Brazil, the use of medicinal plants is mainly based on indigenous practices that, when 
associated with African and Portuguese cultures, generated 
a vast popular experience1. The World Health Organization 
(WHO) recognizes and encourages these practices, as they 
make up what is called Traditional and Complementary 
Medicine.
According to WHO, the majority of the population 
from developing countries “depend on traditional 
medicine for their primary care, considering that 80% 
utilize traditional practices for their basic health care 
and 85% among those people use plants or preparations 
made from them”1. WHO had already warned regarding 
the necessity of regulating the use of medicinal plants and 
phytotherapy at the Alma-Ata conference in 1978, these 
treatmentswere based solely on empirical knowledge and 
popular experience until then, as mentioned1.  
Thus, the National Policy of Medicinal Plants and 
Phytotherapy, was stated in Decree # 5,813, dated June 
22nd, 2006, and implemented actions capable of promoting 
improvements in the well-being of the Brazilian population 
and thereby fostering, among other results, improvement 
in healthcare (1). That policy complies with Primary Care 
as proposed by WHO, which focuses its attention on the 
person and not just the disease and addresses the most 
common problems in the community, providing prevention, 
treatment, and rehabilitation services, maximizing health 
and well-being2. An Inter-ministerial Ordinance # 2,960, 
dated December 9th, 2008, approved the National Policy of 
Medicinal Plants and Phytotherapy and created the National 
Committee of Medicinal Plants and Phytotherapy, it grants 
safe and rational use of medicinal plants and phytotherapic 
medicine by the population, making sure it is done safely, 
effectively, and with quality1.
Nineteen other integrative practices have been 
added to the Universal Healthcare System aside from 
phytotherapy, as stated by the National Policy of Integrative 
and Complementary Practices – PNPIC (Decree GM/MS 
#971 and Decree #849/2017). According to Lucas Gaspar 
Ribeiro, who was the coordinator of the Work Group 
(GT) of PICS at the Brazilian Association of Medicine 
of Family and Community in 2018, integrative practices 
are recommended for preventive or curative purposes, in 
multiple situations, such as supportive care or primary 
therapies for acute or chronic clinical conditions. The 
presence of these practices in the Universal Healthcare 
System is responsible for reducing the unnecessary use 
of medicines and, consequently, their adverse effects 
and, thus, improves the resolution and effectiveness of 
treatments and provides increased quality of life to users. 
The increased demand for these services by healthcare 
users has also been encouraging. When considering the 
results, from data collected from e-SUS and Electronic 
Citizen Medical Records in 2016, there have been over two 
million Integrative Practical appointments registered in the 
Basic Healthcare Units (UBS), and among them, eighty-five 
thousand were considered phytotherapy3.
The National Essential Medicine Listing (Rename) 
includes a dozen phytotherapeutic drugs, originating from 
standardized plant species: Artichoke (Cynara scolymus 
L.), “Aroeira” (Mastic) (Schinus terebinthifolius Raddi); 
Aloe Vera (L.) Burm.f ); Chitticum bark (Rhamnus 
purshiana D.C.); “Espinheira-santa” (Maytenus officinalis 
Mabb.); Guaco (Mikania glomerata Spreng.); Devil’s 
Claw (Harpagophytum procumbens); Spearmint (Mentha 
x piperita L.); Soy isoflavone (Glycine max (L.) Merr.); 
Plantago (Plantago ovata Forssk.); Willow (Salix alba 
L.); Cat’s claw (Uncaria tomentosa (Willd. ex Roem. & 
Schult)(4).
Despite their effectiveness and low operating 
costs5, phytotherapy is not uniformly employed throughout 
the entire country. It is still quite often an unfamiliar 
topic for health professionals. These difficulties arise, 
ranging from the correct understanding of the difference 
between phytotherapeutic drugs and medicinal plants. 
These concepts are confused by the population as well 
as by healthcare professionals. There is disagreement 
by ANVISA6 stating that the population uses medicinal 
plants for therapeutic purposes, the effectiveness of which 
is being proven through chemical and pharmacological 
studies. Phytotherapeutic drugs are obtained by extracting 
the active materials from unprocessed plants through an 
industrialized process and present effectiveness based on 
clinical evidence7. 
Besides that, according to ANVISA6, the 
industrialization process of phytotherapy standardizes the 
quality through the purification of microorganisms and 
foreign substances, thereby making it possible to provide 
enhanced safe usage. 
The riches of the Brazilian plant species and biomes, 
associated with ethnic-cultural diversity, imply extensive 
usage of plants for curative purposes8. Factors, such as 
easy access to these plants and cultural compatibility, are 
extremely relevant to progress in using phytotherapeutic 
drugs, attributing an excellent price-performance ratio to 
such practices5. Primary care services are the leaders in 
prescribing phytotherapy treatments, seeking to establish 
ties between users and healthcare teams7. Thus, using 
phytotherapies promotes the tightening of these bonds 
due to respect for the users’ culture and, thereby, “adding 
meaning to the provision of healthcare and increasing 
adhesion to its practices”7. That effect arises because 
cultural competence, one of the derivative aspects of 
primary healthcare, allows for the recognition of the 
cultural particularities of social groups, as well as an 
understanding of their different necessities and convictions 
about the health-disease process. Thereby, this facilitates 
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the adhesion to the treatment by the user and, consequently, 
making increased effectiveness possible to its prescription2.
Primary Care Professionals can provide specific 
services, varying according to place, time period, and 
that take into consideration variables and relationships. 
Furthermore, they can modulate the agency the patient 
will have in making decisions regarding aspects related to 
the treatment, avoid repetition of exams, medications, and 
organize prescriptions from all specialists2.
However, it is necessary to emphasize that the 
actual institutionalization of the Integrative Practices in 
the Universal Healthcare System is an enormous challenge, 
due to the reduced number of qualified human resources, 
insufficient funding, and limited institutional spaces for 
developing new practices and services. Regardless, due 
to cultural as well as scientific issues, there is a barrier 
to the inclusion of Integrative Practices to biomedicine9. 
The purpose of this work, through a literature review, is to 
identify the most commonly used phytotherapeutic drugs, 
the prevalence of alternative practices use, investigating 
their advantages and disadvantages, and elucidating the 
profile of Universal Healthcare users  and evaluating their.
MATERIAL AND METHODS
This study is based on a literature review, it searched 
for articles through the Scientific Electronic Library Online 
(SciELO) database, performed in the timeframe ranging 
from April 2019 to May of the same year, and, in the 
LILACS database, in July 2019. 
Advanced research was performed in each 
database by inserting the keywords separately and jointly, 
corresponding to the classification of Health Science 
Keywords (DeCS), in Portuguese, as: “Medicamentos 
Fitoterápicos” (Phytotherapeutic Drugs) and “Fitoterapia” 
(Phytotherapy). The inclusion criteria for articles were 
as follow: they had to be written in Portuguese and must 
have been published in the last five years. They had to 
identify the most commonly used herbal medications, the 
prevalence of their use as an alternative practice, stating 
their advantages and disadvantages, and mention the 
profile of the Universal Health Care System Users and 
their evaluation of it. 
A total of three hundred and fifty-three articles were 
found in the SciELO database and, among those, there 
were seventy-seven articles that included the keyword 
“medicamentos fitoterápicos” (phytotherapeutic drugs), 
nine articles were excluded due to repetition, while two 
hundred and seventy-six articles were found including the 
keyword “fitoterapia” (phytotherapy), and six of them were 
excluded due to repetition. After applying the inclusion 
criteria, seventy-eight articles remained. Amidst those, 
fifty-seven were eliminated by the title, as they did not 
meet the inclusion criteria, four of them for having included 
both keywords. Out of the twenty-one selected articles, 
thirteen were chosen to be read and used for preparing 
this literary review. 
A total of one thousand, four hundred, and ninety 
articles were found in the LILACS database, among those, 
four hundred and fifty-nine articles were detected through 
the inclusion of the keyword “medicamentos fitoterápicos” 
(phytotherapeutic drugs), one article was excluded due to 
repetition. One thousand and thirty-one articles were found 
by researching the keyword “fitoterapia” (phytotherapy), 
out of which four were excluded due to repetition. 
Afterwards, with the inclusion criteria, three hundred and 
forty-five articles were focused on. Among those, two 
hundred and ninety-nine were eliminated due to their title, 
as they did not meet the inclusion criteria, and, in the midst 
of these, eleven included both keywords. Amid the forty-six 
lingering eligible articles, eight already were in the SCIELO 
database, thus they were excluded. Among the thirty-eight 
remaining articles, eight were picked for reading and used 
for preparing this literary review. 
The selected articles from the two databases 
encompass bibliographic reviews and original articles. 
Figure 1: The flowchart describes the article 
selection process applied to this bibliographic 
review
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RESULTS AND DISCUSSION
The purpose of this study was to present and discuss 
findings in literature regarding the use of phytotherapeutic 
drugs through the analysis of original studies. The articles 
were read, carefully selected, and described in this context, 
according to Table 1.
Table 1: The listing of the selected articles based on their names, authors, publication magazine, article title, publication year 
Authors Title/Year Findings Conclusion
Mattoset al.10
M e d i c i n a l  p l a n t s  a n d 
phytotherapeutic drugs in Primary 
Health Care:  perception of 
professionals. 2018
96.2% of professionals believe in the medicinal 
effect of plants and phytotherapeutic drugs with 
allopathic medications. 70.7% of professionals 
report the population displays an interest in this 
practice. Nine out of twelve plants or herbal 
medicines (75%) are known by less than half 
(41.4%) of health professionals.
The city of Blumenau did not implement 
the National Policy entirely. Professionals 
agree with the Ministry of Health’s 
initiave, they believe in the therapeutic 
effect of plants; however, they do not 
prescribe them due to lack of knowledge. 
Caccia-Bava et al.7
Availability of phytotherapeutic 
drugs and medicinal plants at the 
São Paulo State primary care units: 
results from the National Program 
of Improved Access and Basic Care 
Quality (PMAQ). 2017
11% of the São Paulo State Healthcare units 
provide phytotherapeutic drugs and medicinal 
plants. Marilia city is noteworthy, in which forty-
four out of forty-five healthcare units provide 
them; Campinas provides them at 65.1% of the 
units and Sorocaba, 50%. Guaco is the most 
commonly used medication.
12% of the interviewed professionals certify that 
their team holds health educational activities 
focusing on the use of medicinal plants and 
herbal medicines. 
It has been proven that phytotherapy 
is present in cities well-rated in human 
development indicators. The increase in 
scientific publications optimistic about 
these medications was emphasized, in 
counterpart to detrimental essays regarding 
the use of industrialized medications 
instead of manipulated medications or 
herbal drugs.
Machado et al.13
Research and extension activities 
in phytotherapy performed by the 
“Rede FitoCerrado” (FitoCerrado 
Network): the rational use of 
medicinal plants and herbal 
medications by the elderly in 
Uberlândia-MG. 2014
Ginkgo biloba and Aesculus hippocastanum 
(horse chestnut) are mentioned as the most 
commonly used herbal medications. 5.5% of those 
interviewed took herbal medications, and 76.7% 
reported on taking some medicinal plants. 60.7% 
of the elderly declared that they did not inform 
the doctor of using medicinal plants and herbal 
medications. 
The importance of performing extension 
activities for improving the usage of 
phytotherapy among the elderly and also 
for making scientific knowledge available 
to the population.
Varela; Azevedo11
Knowledge of herbal medicine and 
its practice by doctors in the family 
healthcare strategy. 2014
It emphasizes the use of phytotherapeutic drugs 
by professionals who did not have access to 
these subjects in college, but they prescribe 
them based on their clinical experience. As 
follows: (1) anxiolytics and sedatives: Remilev, 
Calman, Floriny, and Passiflorine, Ansiopax; 
(2) Ginseng for anxiety and insomnia; (3) 
female demographic: Mencirax, isoflavone, and 
Promensil; (4) Kronel, with antimicrobial, anti-
inflammatory, and healing activities.
The article demonstrated that the majority 
of interviewed doctors were familiar with 
herbal medications and recommended 
them to ESF users from Caicó. Despite the 
lack of instruction regarding this type of 
medication in the training of professionals, 
they are receptive to herbal medication 
practices in ESF.
Nascimento Júnior et 
al.12
Evaluation of the knowledge and 
perception of professionals from 
family healthcare strategy about 
the use of medicinal plants and 
phytotherapy in Petrolina-PE, 
Brazil. 2016
66.7% of the 96 graduated professionals did not 
know the difference between phytotherapeutic and 
homeopathic medicines. 
Despite that, 36.5% confirmed that they prescribe 
them; the majority of doctors are between 31and 
40 years old. 67% of these professionals were 
not taught during their training how to these 
medications. Guaco (Mikania glomerata S.), 
Maracugina, (Passiflora alata A., Erythrina 
mulungu M., and Crataegus oxyacantha L.) and 
Tensart (Passiflora incarnata L.) were the most 
commonly cited.
Training and motivation are necessary, 
so that healthcare professionals become 
able to prescribe Medicinal Plants and 
Phytotherapeutic drugs. It is essential to 
include subjects such as Phytotherapy in 
their curriculum, in order to cover this 
subject and prepare professionals, as well 
as promoting periodic update courses. 
Borcard et al.17
Ethnopharmacological study 
regarding the urban forest as a 
subsidy for the implementation 
of Phytotherapy in the Universal 
Healthcare System. 2015
80% of the interviewed parties classify their 
interest level in learning more about PNPIC, 
PEPIC, and Phytotherapy ranging from 8 to10. 
One hundred and two residents were also 
interviewed, 47% of them confirmed that they 
use PM/Phytotherapy, and they did not inform 
the doctor of their use. 
32 Local Specialists were interviewed, 95% of 
them shared their knowledge with others, mainly 
with neighbors and family members. 
There is l i t t le knowledge of PM/
Phytotherapy and its policies in PHCS 
(primary healthcare services), as self-
teaching is the most common mean for 
obtaining this type of knowledge. The 
importance of this knowledge and its 
perpetuation into future generantions is 
evident to local specialists. 
Feitosa et al.21 Phytotherapy Subject Matter in the Field of Healthcare Courses. 2016
70.8% of the interviewed students are in favor 
of adding medicinal plants and phytotherapy 
subjects to their undergraduate medicine course. 
The majority (81.3%) of the students confirmed 
they were unfamiliar with PNPIC.
Even though they were unfamiliar with 
the integrative regulatory practices, 
most displayed self-taught interest on 
the subject. 
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Authors Title/Year Findings Conclusion
Oliveira; Lucena18 Usage of medicinal plants by the residents of Quixadá–Ceará. 2015
57.41% report that they use medicinal plants, 
among those people, 93.37% drink tea as a 
medication, and 6.63% use it as food. The age 
bracket ranging from 51 to 60 years old knows 
more information on medicinal plants. 97% are 
unfamiliar with the toxicity risks from prolonged 
use of some medicinal plants, such as “boldo.” 
Residents in Quixadá-Ceará frequently use 
medicinal plants. Tea is mainly drunk by 
women and it is done for healing purposes 
and disease prevention. The population is 
unaware as to the usage and dosages. 
Soares et al.22
Pharmacological evaluation and 
assessment of the labeling of 
“boldo” plant drugs (Peumus 
boldus Molina) and chamomile 
(Matricaria recutita L.) for sale in 
Fortaleza, CE. 2015
35.7% of the samples of “boldo” tea and 57.7% of 
the samples of chamomile exceeded the maximum 
concentration of foreign material; 100% of 
the “boldo” samples and 96.6% of chamomile 
presented errors or missing information on the 
labels. 
It is necessary to improve inspection and 
intervention in the production and sale 
of these products to adhere to current 
applicable standards.  
Dias et al.23
Using herbal medications based on 
“aroeira” (mastic) as an assistant 
in the treatment of gingivitis: 
Systematic Review. 2015
Five reviews related to the use of herbal 
medications on the treatment of oral lesions 
conffirm the applicability of “aroeira” (mastic) 
against gingivitis, except 1), one randomized 
clinical study, one experimental study, and one 
descriptive observational study.
“Aroeira” (mastic) was concluded as 
displaying antifungal and antimicrobial 
activities and reduction of gum bleeding 
rates.
Kuba; Vattimo24
Using oriental herbal medications 
in renal lesions: integrative review. 
2015
It performed a bibliographic review on the 
evaluation of 12 studies, 11 of those reported 
on herbal medications effectiveness in either 
preventing or improving renal lesions.
It is necessary to know the risks, 
interactions, toxicity, active mechanisms, 
and adverse effects of these medications.
Piriz et al.25
Medicinal plants in the healing 
process of wounds: a literature 
review. 2014
It performed a bibliographic review on 57 selected 
articles. It identified a total of 52 medicinal 
plants and an herbal mixture that were studied 
experimentally or clinically on its auxiliary 
effects in the healing process, confirming that the 
majority (88.5%) displayed efficacy.
The utilization of medicinal plants 
considers an important alternative in the 
treatment of wounds, showing the need 
for performing further studies and updating 
the subject. 
Figueredo et al.27
The National Policy on Medicinal 
Plants and Herbal Medications: 
construction, perspectives, and 
challenges. 2014
Based on the performed analysis, it was noticed 
that the implementation of the National Policy on 
Medicinal Plants and Herbal Medications made 
little progress regarding the hindrances to its 
use in SUS (Universal Health Care system), due 
to the insufficient knowledge of the healthcare 
professionals.
Despite the challenges, it focused on the 
Policy, as it is important for providing 
means of complementary treatment, 
which is accessible and favors public 
engagement.
David; Bello14
Prescription of herbal medication 
by nutritionists in compounding 
pharmacies. 2017
Camellia sinensis was the most commonly used, 
due to its main purpose of controlling weight. 
Its anti-obesity effect consists of a decrease in 
adipose tissue, since it reduces adipocytes.  
Due to the recent regulation for nutritional 
health professionals, it is important to 
identify their preferences on the selection 
of herbal medication.
Marques et al.15
Characterization of medicinal 
plants and phytotherapeutic drugs 
for the treatment of osteoporosis 
used in Brazil. 2016
The article mentions Glycine max (Soybeans), 
Trifolium pratense (Red clover), Cimicifuga 
racemosa (Black cohosh), and Curcuma longa 
(Turmeric) as alternatives in the treatment of 
osteoporosis in Brazil.
Phytotherapeutic Drugs are presented as 
alternative medications.
Sousa; Tesser16
Traditional and Complementary 
Medicine in Brazil: insertion in the 
Universal Healthcare System and 
integration with primary care. 2017
Traditional and Complementary Medicine can be 
inserted in two or more factors of the network, 
focusing its supply in primary care, and most 
of that supply should be performed through the 
Universal Healthcare System. 
The suggestion of expanding traditional 
and Complementary Medicine in SUS 
(Universal Healthcare System) so as to not 
waste preexisting experiences. 
Araújo et al.20
Difficulties faced by nurses in 
the  appl icabi l i ty  of  herbal 
medications in primary healthcare: 
an integrative review. 2015
Absence of planning, insufficient skills of 
healthcare professionals, and non-valorization by 
the administration and the respective healthcare 
team. 
Increased investment by administrators 
in  implement ing in tegra t ive  and 
complementary practices, as well as in 
the preparatory process. 
Darroz et al.26
Utilization of herbal medications 
in the treatment of intestinal 
constipation. 2014
Psyllium Mill, a laxative that increases the stool 
bulk, castor oil, and anthraquinone compounds as 
secretagogic laxatives, were cited. They include 
Aloe vera, Chitticum bark (Rhamnus purshiana),
Chinese rhubarb (Rheum palmatum), and 
Alexandrian senna (Cássia angustifolia).
There are awareness programs for 
discussing adverse effects from taking 
laxatives and the need for changes in diet 
and lifestyle. 
Sá et al.19
Evaluating the impact on the 
Brazilian policy of medicinal 
plants and phytotherapeutic 
compounds in healthcare college 
education. 2018
The PNPMF depends on intrinsic and extrinsic 
factors regarding education in order to achieve 
the expected results. There has been little impact 
on healthcare college curriculums in Ceará State. 
Except for what has been done in pharmacy 
courses. 
It is essential to improve instruction on 
phytotherapy in college teaching, as well 
as other integrative practices.
Table 1: The listing of the selected articles based on their names, authors, publication magazine, article title, publication year                   Continuation
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The selected articles were arranged in four 
categories, based on the content analysis and the purpose of 
the discussion: A) Most commonly used phytotherapeutic 
substances; B) Determination of prevalence of phytotheray 
usage; C) Advantages and disadvantages of using 
phytotherapeutic medication; D) The profile and evaluation 
of users in the Universal Healthcare System regarding the 
usage of phytotherapeutic drugs. The following topics will 
discuss such categories.
Most commonly used phytotherapeutic substances
The Universal Healthcare System started to 
implement phytotherapy in 2006, when the Ministry of 
Health launched the National Policy of Integrative and 
Complementary Practices (PNPIC)10, studies regarding 
the use of this practice became more frequent, making it 
possible to make comparisons. 
The first analyzed article7 evaluated the availability 
of phytotherapeutic drugs in primary healthcare units in 
the state of São Paulo, “recommending Guaco (Mikania 
glomerata) traditionally broadly presented due to its 
expectorant and bronchodilator actions”7.
One study11 carried out in the family healthcare 
strategy framework in Caicó, in Rio Grande do Norte state, 
focused on the proven anxiolytic and sedative activity, such as 
Remilev, made of valerian (Valeriana officinalis); Calman, 
Floriny, and Passiflorine, prepared with “passiflora” 
(passion fruit) (Passiflora incarnata); Ansiopax, extracted 
from kava kava (Piper methysticum); Ginseng (Panax 
ginseng C. A. Mey.), used in treating anxiety and insomnia.
Varela and Azevedo11 also identified the use 
of phytotherapeutic medicine targeted to a female 
demographic, as Mencirax, made from a dry extract 
of “cimicífuga” (black cohosh) (Cimicifuga racemosa 
L.); Kronel, prepared from “aroeira” (mastic) (Schinus 
terebinthifolius Raddi), which provides antimicrobial, 
anti-inflammatory, and healing properties; isoflavone, 
eases vasomotor symptoms, caused by menopause, and 
Promensil, prepared with red clover (Trifolium pratense), 
however, it provides questionable efficacy, as it does 
not promote significant improvement of menopausal 
symptoms; and tibolone.
There was another research study12 performed on the 
family healthcare strategy in Petrolina-PE, the medications 
cited in the interviews were: Guaco® (Mikania glomerata 
S.) (4 mentions); Maracugina® (made from passion fruit) 
(Passiflora alata A., Erythrina mulungu M. and Crataegus 
oxyacantha L.) (2 mentions); Tensart® (Passion Fruit) 
(Passiflora incarnata L.) (2 mentions)12, thus, these are in 
agreement with the other analyzed articles. And finally, a 
study13 performed in Uberlândia-MG, focused on Ginkgo 
biloba and Aesculus hippocastanum, as the most commonly 
used Phytotherapeutics.
Green tea, Camellia sinensis, according to one of 
the research essays14 is primarily prescribed by nutritionists 
to promote weight loss. The literature15 also mentions 
phytotherapeutic drugs made of Curcuma (Turmeric) due 
to its bone protective properties, presenting as an alternative 
treatment for osteoporosis. 
Prevalence of phytotherapeutics usage
Around 25% of Brazilian cities, in 2008, offered 
some approaches among Traditional and Complementary 
medicines, based on the context and local needs16. In 2014, 
only 16.1% primary healthcare units in São Paulo state 
offered these drugs, as evidenced by a research study13 
performed on 292 elderly people who were over 60 years old 
and were enrolled in Physical and Recreational programs 
for the Elderly in Uberlândia-MG. It confirmed that 5.5% 
of the interviewed participants used phytotherapeutic 
drugs, while the majority of the interviewed did not know 
that term. Conversely, 76.7% reported that they used some 
medicinal plants.
Patients commonly use medicinal plants, yet they 
do not report it to their doctors, as confirmed in one study17 
performed among the 102 users of the Primary Healthcare 
Unit in Juiz de Fora (MG), whereas 47% confirmed that 
they did not report this fact. Medicinal plants are lower 
priced when compared to phytotherapeutic and allopathic 
drugs. Also, they are associated with traditions and 
publc knowledge, as evidenced in the same study (18) that 
interviewed 32 local specialists in that same region. 95% 
of these people confirmed that they shared their knowledge 
with others, especially family members and neighbors. 
In the study, as mentioned earlier17 in Juiz de Fora 
(MG), 142 healthcare professionals were interviewed, and 
none of them knew how to define the term phytotherapy. 
58.4% were self-taught on their knowledge about the 
subject, and only 13% confirmed to have obtained 
that knowledge in university17. One study12 on 96 
bachelors in Family Healthcare Strategy in Petrolina-PE 
confirmed that 66.7% did not know the difference between 
phytotherapeutic and homeopathic medications and, despite 
that, 36.5% confirmed that they prescribed these drugs. The 
majority of these doctors were aged between 31 and 40. 
While in a similar research study10 performed from 2014 to 
2015 in Blumenau-SC, analyzing 157 Family Healthcare 
professionals in the city, 85.4% of them did not know 
about the presence of phytotherapeutic medicine listed on 
the National Listing of Essential Medications and, despite 
this, 84.7% had already previously prescribed them to 
their patients. 
In Caicó (RN), there was a research study11 
performed in 2011, including nine doctors that suggested 
that they had little knowledge of phitotherapy and had little 
instruction on this subject in their undergraduate course. 
But, contrary to other studies, the professionals, despite 
not having technical preparation, confirmed that they were 
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knowledgeable on specific drugs due to the many years 
they had practiced medicine and their experiences, and they 
reported that they had prescribed them to their patients, 
especially anxiolytic/sedative phytotherapeutic drugs to 
substitute benzodiazepines 
Regarding the prevalence of phythotherapy related 
knowledge by healthcare professionals, the southeast region 
presents the largest number of specialists in phytotherapy 
(42%), probably due to the higher concentration of 
healthcare professionals in these big healthcare centers. 
There are 20% in the northeast region, followed by 15% in 
the southern region, then 13% in the central-western, and, 
finally, 10% in the northern region19.
Almost all the studies indicated that the majority of 
the components of either group — healthcare professional 
and users — use,or have already used, some medicinal 
plants, mainly as teas. Regardless, they do not recommend 
the use of phytotherapy for various treatments. 
Advantages and disadvantages of using phytotherapeutic 
medicine 
Based on the analysis of the first article10, a 
detrimental outlook was placed on the outlook of users 
regarding medicinal plants, as they do not consider  they 
might have any harmful effects since they are natural, 
leading to the user not informing the doctor of such use. Yet, 
medication interactions may occur with allopathic drugs, 
as well as other toxic effects to the organism when used in 
excess13,18. Unfamiliarity is also stressed10, regarding the 
interviewed professionals on plants listed in RENAME, 
thereby hindering their prescription. However, the study10, 
besides revealing that professionals believe in the practice 
and confirm their utilization by the local population, some 
medicinal plants have been emphasized, as they have 
already gone through all the research study steps and, 
thereby, they are considered sufficiently effective to be 
part of the medication arsenal of healthcare professionals. 
Additionally, the phytotherapeutic practice allows for the 
population to be in contact with its history, recovering 
traditional and cultural habits.
An increase in scientific publications on phytotherapy 
has been noted since 2003, through analyzing a study7 on the 
availability of phytotherapeutic drugs in primary healthcare 
in São Paulo State, especially on their insertion in primary 
healthcare, fostered by the regulatory approval of the 
practice in Brazil and after publications from PNPIC and 
PNPMF. The article7 emphasizes the importance of using 
phytotherapeutic drugs in primary healthcare in the cities of 
São Paulo, evolving from the main factor of the existence 
of municipal laws assuring that these programs remain 
independent from changes in political administrations, as 
states law # 13,888 dated July 19, 2010, authorizing the 
implementation of the Phytotherapeutic Municipal Program 
in the Public Healthcare Network in the city of Campinas 
and law # 14,903, dated February 6, 2009, on the creation 
of the Phytotherapeutic and Herbal Medicine Program in 
São Paulo City. In counterpart, research study7 negatively 
emphasizes the use of industrialized phytotherapeutic 
medicine instead of compounded ones or herbal drug 
medications, displaying the need for this segment of the 
Brazilian industry so that the use of these medications is 
not negatively impacted due to their absence on the market.
According to the research study 13 on the Fitocerrado 
network on phytotherapeutic medicine, the mistakes 
in the preparation and identification of herbal species 
and excessive use might impose hazards, causing an 
overdose, absence of efficacy, undesirable effects, that 
can compromise the user’s health. Problems, such as 
the absence of dialogue among Universities publishing 
scientifically about the subject and the population, 
propagating empirical knowledge, such as therapeutic 
recommendations, toxicity, contraindications, and possible 
interactions, are also emphasized in the article12.
The study analysis 11 on phytotherapeutic knowledge 
and practices among doctors in primary healthcare stated 
that this practice is beneficial to the economy, as around 
US$22 billion are transacted annually by the world-wide 
phytotherapeutic market, and Brazil is abundant in a 
great diversity of plants used as medication precursors, 
showing its great potential in this market. The preference 
of professionals is furthermore positively reinforced while 
prescribing phytotherapeutic medicine in cases of insomnia 
and anxiety, which are considered as adequate, instead 
of using benzodiazepines and even associated with anti-
hypertensive drugs for preventing anxiety, as sometimes 
it is associated to this condition. 
However, this research study11 also states 
disadvantages as undergraduate medical courses fails to 
introduce the budding doctor to integrative practices, and, 
thereby, causes a low degree of adhesion of the professional 
to this therapy alternative. Associated to that, family 
members and friends become the source of information on 
phytotherapy, that can bring about various harmful effects, 
since there is not any medical basis, instead of getting that 
information from a healthcare professional. 
Araújo et al.20 pointed out that nurses find it 
challenging to apply Phytotherapy in Primary Healthcare 
and that contributes to those negative aspects, being that the 
main hindrances encountered are: the absence of planning in 
the implementation of these and other integrative practices 
in primary healthcare: the lack of professional healthcare 
training and the recognition by the administration and the 
respective healthcare team20.
In counterpart, there is a research study21 on the 
insertion of phytotherapeutic contents in the segment of 
healthcare courses, focused on interviewing students from 
medical, nursing, and dentistry courses, which are favorable 
to the addition of course contents about phytotherapy in 
the undergraduate curriculum, even though they do not 
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entirely know the efficacy and the recommendations of 
this practice. This way, a professional can be expected 
to be more assured of acting in the Universal Healthcare 
System, thereby preserving the right of the users to choose 
alternative treatments. 
The negative aspects of the practice are stated 
in the article22, on the pharmacological evaluation and 
phytotherapeutic labeling, emphasizing the presence of dirt 
and foreign organic matter in evaluated samples exceeding 
the acceptable limit and errors on the labels, such as the 
absence of the scientific names of the botanical species, 
batch identification, and preparation manner, among other 
items. It is necessary to employ stricter surveillance in 
controlling Phytotherapeutics to assure the quality and 
desired effect in the health of the consumer. 
There  i s  a  pos i t ive  emphas is  on  us ing 
phytotherapeutic medicine in specific bodily processes that 
were observed throughout the analyses. The antimicrobial 
property of aroeira (mastic) extract23 is proven to show 
promising results in controlling microorganisms related 
to oral pathologies23 that justify its use in the treatment 
of gingivitis. Similarly, the relevance of phytotherapy 
in renal alterations24 is emphasized, mainly by acting in 
changing the nephrite genetic expression, modulation of 
the renal system - renal angiotensin, antioxidant effects, and 
modulation in the production of nitric oxide24. Likewise, 
the benefit is emphasized in “the aqueous extract of 
Stryphnodendron adstringens (Mart.) Coville, which is 
traditionally used in Brazil for its healing properties”25.
This study15 on phytotherapeutic medicine used 
primarily in the treatment of osteoporosis in young women, 
reveals the benefits of medications such as isoflavone, 
or even phytotherapeutic drugs made of turmeric to 
“avoid major deterioration of the osseous structures and 
produce beneficial changes in osseous remodeling”15, and 
diminishing osteoclastogenesis. Another study26 stresses 
the advantage of using phytotherapy in the treatment of 
intestinal constipation, emphasizing medications distilled 
from Senna, Chinese rhubarb, and Chitticum bark that 
act as laxatives, as well as castor oil and derivatives of 
aloe vera.
One study27 on the construction, perspective, and 
challenges of PNPMF also expresses the benefits from the 
use of medicinal plants and phytotherapeutic medicine as 
they can be used in the manufacturing of industrialized 
medications, compounded medication, or by using plants, 
through homemade preparations27. The article27 states 
that phytotherapeutic substances from eleven plants are 
included in the list of pharmaceutical treatment medications 
in primary healthcare, and it identifies funding as one of 
the hindrances in obtaining access to the practice. The 
authors report that the Universal Healthcare System is 
inserted in a model that uses synthetic medication, and 
the implementation of a new dynamic would imply 
new costs. Even though phytotherapy is a low-cost 
treatment, its structuring would incur investments in 
professional qualification, setting up phytotherapeutic 
drug manipulation, and the supply of precursor materials. 
The profile and evaluation of users of the Universal 
Healthcare System regarding the use of phytotherapeutic 
medicine
Although there is a limitation in the field of research 
and there is no data on the subject on a national level, it 
is possible to find a public standard regarding the use of 
phytotherapeutic medicine. However, there is a greater 
prevalence of use among women and individuals over 50 
years of age. According to a study13 performed in Uberlândia 
(MG), the main contributing factors for the increased use 
among the elderly include low cost; easy access, difficult 
access to medications in healthcare services; fewer adverse 
effects when compared to conventional medicines; cultural 
tradition, and preference for natural products13.
Regarding the evaluation of the practice by users 
who were interviewed for the study28 in the Universal 
Healthcare System, they confirmed that the pharmacological 
action from synthetic medications is quicker than medicines 
made from plants, especially as they are “stronger,” they 
also believe that they are more effective in more severe 
cases. In counterpart, even though phytotherapeutic drugs 
are slower acting, they are gentler. On the other hand, 
in a study29 performed in Palmares (RJ), 98% of those 
interviewed were unaware of the concept of phytotherapy 
and the possibility of this type of treatment in the Universal 
Healthcare System. Thus, despite the expansion of the 
practice, it is possible to infer that the users also need to 
be better informed regarding this subject. 
CONCLUSION
According to the evaluated profile and methodology 
of the study, it is possible to establish Guaco (Mikania 
glomerata) and phytotherapeutic medicine made of 
Passiflora (passion fruit) as the most commonly used plant 
based treatments; the former, due to its bronchodilator 
and expectorant action and the latter for its anxiolytic 
properties. The literature also mentions green tea, Camellia 
sinensis, which is prescribed by nutritionists for promoting 
weight loss, and phytotherapeutic substances distilled from 
Turmeric, due to its osseous protective effect. 
Regarding the prevalence of phythotherapy related 
knowledge by healthcare professionals, the southeast 
region has displayed a more significant number of 
specialists in phytotherapy (42%), probably due to the 
higher concentration of health professionals in large 
city centers. However, in the general, the studies have 
pointed out unawareness by users and health professionals 
regarding phytotherapy, and related to that is the fact that 
the Universal Healthcare System offers a smaller quantity 
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of phytotherapeutic drugs compared to allopathic drugs. 
In counterpart, the tightening of the bond with the patient, 
related to their cultural roots and family members, is 
emphasized as a positive aspect in taking Phytotherapeutics. 
The user profile taking phytotherapy includes women and 
individuals over 50 years of age. Users declared that they 
prefer taking phytotherapeutic medicine in less severe 
situations, as they believe their actions are slower and 
gentler. However, the literature states that the greatest 
majority of users are unaware of the possibilities of 
using phytotherapy. Thus, it emphasizes the necessity for 
fostering more studies on the practice, seeking to expand 
knowledge, and encouraging alternative forms of careful 
production, so that it adjoins the population within its 
ethnic-cultural peculiarities.
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